Lauren E. Colbert

Cancer therapy in the necroptosis era

Ferroptosis: molecular mechanisms and health implications

Ferroptosis: Death by Lipid Peroxidation

Necroptosis and its role in inflammation

Regulated cell death and inflammation: an auto-amplification loop causes organ failure

Targeting Ferroptosis to Iron Out Cancer

Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death

Inflammaging: a new immune–metabolic viewpoint for age-related diseases

Immunogenic cell death in cancer and infectious disease

The molecular machinery of regulated cell death

Macrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines

HSP90 activity is required for MLKL oligomerisation and membrane translocation and the induction of necroptotic cell death

Glutaminolysis and Transferrin Regulate Ferroptosis

Acute kidney injury

Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores

Regulated necrosis: the expanding network of non-apoptotic cell death pathways

Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes

Initiation and execution mechanisms of necroptosis: an overview

ROS Are Good

Necroptosis: an alternative cell death program defending against cancer

NF-κB, inflammation, immunity and cancer: coming of age

Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases

Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity

Cell death: a review of the major forms of apoptosis, necrosis and autophagy

Pronecrotic mixed lineage kinase domain‐like protein expression is a prognostic biomarker in patients with early‐stage resected pancreatic adenocarcinoma